Search research articles
Contact Us
Filters
Showing results (571-580 of 583) with videos related to
Page
of 59
Sort By:
Urologic Oncology
|
July 27, 2013
Individualized renal mass biopsy strategy for Chinese patients with different subtypes and necrosis area
Guo H Shi, Ying Chen, Xu D Yao, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
November 9, 2010
[The survival analysis of metastatic prostate cancer]
Chun-Guang Ma, Ding-Wei Ye, Xu-Dong Yao, et al.
Urologic Oncology
|
January 1, 2020
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients
Yang Qu, Zhiyuan Lin, Yu Qi, et al.
British Journal of Cancer
|
June 6, 2018
RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway
Jian-Ye Liu, Qing-Hai Zeng, Pei-Guo Cao, et al.
Neoplasia (New York, N.Y.)
|
December 29, 2024
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma
Shu Wang, Hong Chen, Bo Dai, et al.
Molecular & Cellular Proteomics : MCP
|
April 15, 2026
Plasma proteomic profiling was used to discover a biochemical recurrence prediction model for prostate cancer
Ning Xu, Linhui Zhang, Zhenmei Yao, et al.
Cancer Discovery
|
November 14, 2025
PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis
Shuang Tang, Qian Zhou, Johann S Bergholz, et al.
Journal of Hematology & Oncology
|
June 18, 2026
BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88<sup>L265P</sup>-induced PIM1 stability
Yan Yuan, Bo Dai, Haoshu Zhong, et al.
Cancer Research
|
November 7, 2019
Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth
Yuan-Yuan Qu, Rui Zhao, Hai-Liang Zhang, et al.
BMC Medicine
|
July 1, 2026
Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysis
Jun-Long Wu, Shu-Suan Jiang, Hong Luo, et al.
Page
of 59
Search research articles
Search
Showing results (571-580 of 583) with videos related to
Sort By:
Page
of 59
Urologic Oncology
|
July 27, 2013
Individualized renal mass biopsy strategy for Chinese patients with different subtypes and necrosis area
Guo H Shi, Ying Chen, Xu D Yao, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
November 9, 2010
[The survival analysis of metastatic prostate cancer]
Chun-Guang Ma, Ding-Wei Ye, Xu-Dong Yao, et al.
Urologic Oncology
|
January 1, 2020
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients
Yang Qu, Zhiyuan Lin, Yu Qi, et al.
British Journal of Cancer
|
June 6, 2018
RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway
Jian-Ye Liu, Qing-Hai Zeng, Pei-Guo Cao, et al.
Neoplasia (New York, N.Y.)
|
December 29, 2024
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma
Shu Wang, Hong Chen, Bo Dai, et al.
Molecular & Cellular Proteomics : MCP
|
April 15, 2026
Plasma proteomic profiling was used to discover a biochemical recurrence prediction model for prostate cancer
Ning Xu, Linhui Zhang, Zhenmei Yao, et al.
Cancer Discovery
|
November 14, 2025
PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis
Shuang Tang, Qian Zhou, Johann S Bergholz, et al.
Journal of Hematology & Oncology
|
June 18, 2026
BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88<sup>L265P</sup>-induced PIM1 stability
Yan Yuan, Bo Dai, Haoshu Zhong, et al.
Cancer Research
|
November 7, 2019
Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth
Yuan-Yuan Qu, Rui Zhao, Hai-Liang Zhang, et al.
BMC Medicine
|
July 1, 2026
Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysis
Jun-Long Wu, Shu-Suan Jiang, Hong Luo, et al.
Page
of 59